上海市广发律师事务所 在本法律意见书中，本所律师根据《股东会规则》的要求，仅就本次股东大 会的召集、召开程序是否合法及是否符合《公司章程》、出席会议人员资格和会 议召集人资格的合法有效性、会议表决程序和表决结果的合法有效性发表意见， 而不对本次股东大会所审议的议案内容和该等议案中所表述的事实或数据的真 实性和准确性发表意见。 关于卫宁健康科技集团股份有限公司 本法律意见书仅供本次股东大会之目的使用，不得被任何人用于其他任何目 的。本所同意，公司可以将本法律意见书作为公司本次股东大会公告材料，随其 他需公告的信息一起向公众披露，本所依法对发表的法律意见承担责任。 本所律师根据相关法律、法规和规范性文件的要求，按照律师行业公认的业 务标准、道德规范和勤勉尽责精神发表意见如下： 一、本次股东大会的召集和召开程序 2025 年第一次临时股东大会的法律意见书 致：卫宁健康科技集团股份有限公司 卫宁健康科技集团股份有限公司（以下简称"公司"）2025 年第一次临时 股东大会于 2025 年 10 月 15 日在上海市静安区寿阳路 99 弄 9 号卫宁健康大厦 16 楼会议室召开。上海市广发律师事务所经公司聘请，委派成赟律 ...

证券代码：300253 证券简称：卫宁健康 公告编号：2025-077 卫宁健康科技集团股份有限公司 2025 年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决议案的情形； 2、本次股东大会不涉及变更以往股东大会已通过的决议； 3、中小投资者是指除上市公司董事、监事、高级管理人员以及 单独或者合计持有公司 5%以上股份的股东以外的其他股东。 一、会议召开和出席情况 卫宁健康科技集团股份有限公司（以下简称"公司"）董事会于 2025 年 9 月 30 日以公告形式发布了《关于召开 2025 年第一次临时 股东大会的通知》，本次股东大会以现场投票与网络投票相结合的方 式进行。 现场会议召开时间为：2025 年 10 月 15 日（星期三）14:30；会 议地点为：上海市静安区寿阳路 99 弄 9 号卫宁健康大厦 16 楼会议室； 网络投票时间为：2025 年 10 月 15 日，其中，通过深圳证券交易所 交易系统进行网络投票的具体时间为：2025 年 10 月 15 日 9:15-9:25， 9: ...

Core Insights - The company, Weining Health, reported that as of October 10, 2025, the number of shareholders is 116,441 [1] Company Summary - Weining Health's shareholder count is projected to reach 116,441 by October 10, 2025 [1]

Core Viewpoint - The stock of Weining Health has shown a mixed performance in recent trading sessions, with a year-to-date increase of 25.82% but a decline in the last five, twenty, and sixty days [1][2]. Financial Performance - As of September 30, Weining Health reported a revenue of 839 million yuan for the first half of 2025, representing a year-on-year decrease of 31.43%. The net profit attributable to shareholders was -118 million yuan, a significant decline of 491.04% compared to the previous year [2]. - Cumulative cash dividends since the A-share listing amount to 455 million yuan, with 97.23 million yuan distributed over the last three years [3]. Shareholder Information - The number of shareholders as of September 30 is 117,300, a decrease of 0.45% from the previous period. The average number of tradable shares per person increased by 0.49% to 16,323 shares [2]. - As of June 30, 2025, the top ten circulating shareholders include Huabao Zhongzheng Medical ETF and E Fund Growth Enterprise ETF, with notable changes in their holdings [3]. Stock Market Activity - On October 15, Weining Health's stock price rose by 2.04% to 8.99 yuan per share, with a trading volume of approximately 99.64 million yuan and a turnover rate of 0.58%. The total market capitalization stands at 19.91 billion yuan [1]. - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent occurrence on February 7 [1].

Core Viewpoint - The stock of Weining Health has experienced a decline in recent trading sessions, with a notable drop in both revenue and net profit for the first half of 2025, indicating potential challenges for the company moving forward [1][2]. Company Overview - Weining Health Technology Group Co., Ltd. is based in Shanghai and was established on April 7, 2004, with its listing date on August 18, 2011. The company specializes in the research, development, sales, and technical services of medical software, providing comprehensive solutions for the healthcare industry's information technology [1]. - The main revenue composition of the company includes software and services (84.65%), hardware sales (7.89%), and internet healthcare (7.46%) [1]. Financial Performance - As of September 30, Weining Health reported a revenue of 839 million yuan for the first half of 2025, representing a year-on-year decrease of 31.43%. The net profit attributable to the parent company was -118 million yuan, a significant decline of 491.04% compared to the previous year [2]. - The company has cumulatively distributed 455 million yuan in dividends since its A-share listing, with 97.23 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, Weining Health had 117,300 shareholders, a decrease of 0.45% from the previous period. The average number of circulating shares per shareholder increased by 0.49% to 16,323 shares [2]. - The top circulating shareholders include Huabao Zhongzheng Medical ETF, which holds 58.77 million shares, and Yifangda Growth Enterprise Board ETF, holding 45.26 million shares, with some changes in their holdings compared to the previous period [3].

Core Viewpoint - Multiple shareholders across various companies are planning to reduce their stakes, indicating potential shifts in ownership dynamics and investor sentiment in the market [1] Shareholder Reductions - Luzhou Chemical plans to reduce its stake by no more than 1% [1] - New Agricultural Co. director and vice president Zhang Jianrong intends to reduce his holdings by no more than 570,000 shares [1] - Jingquanhua's shareholder Yuan Zhifuhai aims to reduce his stake by 2% [1] - Hengbo shares' shareholder Hainan Mingxu plans to reduce by no more than 3% [1] - Weining Health's senior executive Jin Mao intends to reduce by no more than 1.88 million shares [1] - Sun Cable's shareholder Yili Group plans to reduce by no more than 3% [1] - Zhongjing Technology's Xu Yijun has cumulatively reduced his stake by 1.99% [1] - Tengye Precision's actual controller's concerted action party plans to reduce by 2.99% [1] - Bowen Technology's Shanghai Depeng has reduced its stake by 0.58% [1] - Gaoling Information's Zixiao Investment has reduced its holdings by 663,000 shares [1] - Yuntian Lifa's shareholders Donghai Yuntian and Donghai No.1 have collectively reduced their stakes by 3.1702 million shares [1] - Nobon Co.'s shareholders Jin Nuo Chuang and Ren Jian have completed a reduction of 1.557 million shares [1] - Guangdong Mingzhu's shareholder Mingqiao Stable Selection No.2 private equity fund has reduced its stake by 1.17% [1] Other Notable Events - Hesheng New Materials' director Wu Haifeng is under investigation by public security for suspected illegal loan issuance [1] - Zitian Tui's stock has been delisted and removed from trading [1]

格隆汇10月13日丨卫宁健康(300253.SZ)公布，公司董事、高级管理人员靳茂先生持有公司股份 7,532,336股（占公司总股本比例为0.3423%），计划在本公告披露之日起15个交易日后的3个月内 （2025年11月4日至2026年2月3日，窗口期不减持）以集中竞价方式或者大宗交易方式减持公司股份不 超过1,880,000股（占公司总股本比例为0.0854%）。 ...

Core Viewpoint - The announcement reveals that the company's director and senior executive, Jin Mao, plans to reduce his shareholding in Weining Health Technology Group Co., Ltd. due to personal financial needs [1]. Group 1: Shareholding Details - Jin Mao currently holds 7.532336 million shares, representing 0.3423% of the company's total share capital [1]. - The planned reduction will occur within three months starting from November 4, 2025, to February 3, 2026, during which he will not sell shares in the designated window period [1]. - The maximum number of shares to be sold is 1.88 million, accounting for 0.0854% of the total share capital [1]. Group 2: Compliance and Commitments - Jin Mao's shares for reduction are sourced from pre-IPO shares, equity incentive shares, and shares acquired in the secondary market, including those from rights distributions [1]. - He has adhered to his commitment made during the IPO, which limits his annual transfer of shares to no more than 25% of his total holdings during his tenure and prohibits any transfer within six months after leaving the company [1]. - As of the announcement date, there are no ongoing commitments or guarantees related to the planned share reduction, and he has not violated any commitments [1]. Group 3: Impact on Company Structure - The share reduction plan will not lead to any change in the company's control, governance structure, or operational impact [2]. - The company will continue to monitor the progress of this share reduction plan and fulfill its information disclosure obligations as required [2].

Company Announcement - Wining Health (SZ 300253) announced that Mr. Jin Mao, a director and senior executive, plans to reduce his shareholding by up to 1.88 million shares, representing 0.0854% of the total share capital, within three months starting from 15 trading days after the announcement date [1] Financial Performance - For the first half of 2025, Wining Health's revenue composition is as follows: 92.54% from the healthcare information technology sector and 7.46% from the internet healthcare sector [1] - As of the announcement, Wining Health's market capitalization is 20 billion yuan [1]

关于董事、高级管理人员减持股份的预披露公告 公司董事、高级管理人员靳茂先生保证向本公司提供的信息内 容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供 的信息一致。 特别提示： 证券代码：300253 证券简称：卫宁健康 公告编号：2025-076 卫宁健康科技集团股份有限公司 1、靳茂先生在公司首次公开发行股票并上市时承诺：在其任职 期间每年转让直接或间接持有的发行人股份不超过其所持有股份总 数的百分之二十五；离职后半年内，不转让其直接或间接持有的发行 人股份。 截至本公告披露日，靳茂先生严格遵守了上述承诺，未出现违反 上述承诺的情况。 公司董事、高级管理人员靳茂先生持有公司股份 7,532,336 股 （占公司总股本比例 注1为 0.3423%），计划在本公告披露之日起 15 个 交易日后的 3 个月内（2025 年 11 月 4 日至 2026 年 2 月 3 日，窗口 期不减持）以集中竞价方式或者大宗交易方式减持公司股份不超过 1,880,000 股（占公司总股本比例为 0.0854%）。 卫宁健康科技集团股份有限公司（以下简称"公司"）于 ...